메뉴 건너뛰기
Translational Lung Cancer Research
Volumn 3, Issue 6, 2014, Pages 411-413
Reflections on immune checkpoint inhibition in non-small cell lung cancer
Author keywords

[No Author keywords available]
Indexed keywords

EID: 84959904342     PISSN: 22186751     EISSN: 22264477     Source Type: Journal    
DOI: 10.3978/j.issn.2218-6751.2014.09.09     Document Type: Editorial
Times cited : (9)
References (10)
  • 1
    • 0032736029 scopus 로고    scopus 로고
    • B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
    • Dong H, Zhu G, Tamada K, et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999;5:1365-9.
    • (1999) Nat Med , vol.5 , pp. 1365-1369
    • Dong, H.1    Zhu, G.2    Tamada, K.3
  • 2
    • 18544380239 scopus 로고    scopus 로고
    • Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion
    • Dong H, Strome SE, Salomao DR, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 2002;8:793-800.
    • (2002) Nat Med , vol.8 , pp. 793-800
    • Dong, H.1    Strome, S.E.2    Salomao, D.R.3
  • 3
    • 84891534246 scopus 로고    scopus 로고
    • Programmed death ligand-1 expression in non-small cell lung cancer
    • Velcheti V, Schalper KA, Carvajal DE, et al. Programmed death ligand-1 expression in non-small cell lung cancer. Lab Invest 2014;94:107-16.
    • (2014) Lab Invest , vol.94 , pp. 107-116
    • Velcheti, V.1    Schalper, K.A.2    Carvajal, D.E.3
  • 4
    • 77954899030 scopus 로고    scopus 로고
    • Phase I study of single-agent anti-programmed death-1 (MDX- 1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates
    • Brahmer JR, Drake CG, Wollner I, et al. Phase I study of single-agent anti-programmed death-1 (MDX- 1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol 2010;28:3167-75.
    • (2010) J Clin Oncol , vol.28 , pp. 3167-3175
    • Brahmer, J.R.1    Drake, C.G.2    Wollner, I.3
  • 5
    • 84907614647 scopus 로고    scopus 로고
    • Safety and clinical activity of MK-3475 in previously treated patients (pts) with non-small cell lung cancer (NSCLC)
    • Garon EB, Leighl NB, Rizvi NA, et al. Safety and clinical activity of MK-3475 in previously treated patients (pts) with non-small cell lung cancer (NSCLC). J Clin Oncol 2014;32:abstr 8020.
    • (2014) J Clin Oncol , vol.32
    • Garon, E.B.1    Leighl, N.B.2    Rizvi, N.A.3
  • 6
    • 84959899001 scopus 로고    scopus 로고
    • A novel method for identifying downstream signals in tumor-reactive T cells following PD-1 engagement and monitoring endogenous tumor immunity and immunotherapy
    • Dong H, Zhao W, Krco CJ, et al. A novel method for identifying downstream signals in tumor-reactive T cells following PD-1 engagement and monitoring endogenous tumor immunity and immunotherapy. J Clin Oncol 2014;32:abstr 3049.
    • (2014) J Clin Oncol , vol.32
    • Dong, H.1    Zhao, W.2    Krco, C.J.3
  • 7
    • 84926408087 scopus 로고    scopus 로고
    • Domain-specific PD-L1 protein measurement in non-small cell lung cancer (NSCLC)
    • McLaughlin JF, Schalper K, Carvajal-Hausdorf DE, et al. Domain-specific PD-L1 protein measurement in non-small cell lung cancer (NSCLC). J Clin Oncol 2014;32:abstr 8064.
    • (2014) J Clin Oncol , vol.32
    • McLaughlin, J.F.1    Schalper, K.2    Carvajal-Hausdorf, D.E.3
  • 8
    • 84963986997 scopus 로고    scopus 로고
    • Concordance of PD-L1 expression by different immunohistochemistry (IHC) definitions and in situ hybridization (ISH) in squamous cell carcinoma (SCC) of the lung
    • Marti AM, Martinez P, Navarro A, et al. Concordance of PD-L1 expression by different immunohistochemistry (IHC) definitions and in situ hybridization (ISH) in squamous cell carcinoma (SCC) of the lung. J Clin Oncol 2014;32:abstr 7569.
    • (2014) J Clin Oncol , vol.32
    • Marti, A.M.1    Martinez, P.2    Navarro, A.3
  • 9
    • 84959127317 scopus 로고    scopus 로고
    • Intratumor heterogeneity (ITH) of lung adenocarcinomas defined by multiregion whole exome sequencing (WES)
    • Zhang J, Fujimoto J, Zhang J, et al. Intratumor heterogeneity (ITH) of lung adenocarcinomas defined by multiregion whole exome sequencing (WES). J Clin Oncol 2014;32:abstr 11032.
    • (2014) J Clin Oncol , vol.32
    • Zhang, J.1    Fujimoto, J.2    Zhang, J.3
  • 10
    • 84893362995 scopus 로고    scopus 로고
    • Incorporating immune-checkpoint inhibitors into systemic therapy of NSCLC
    • Champiat S, Ileana E, Giaccone G, et al. Incorporating immune-checkpoint inhibitors into systemic therapy of NSCLC. J Thorac Oncol 2014;9:144-53.
    • (2014) J Thorac Oncol , vol.9 , pp. 144-153
    • Champiat, S.1    Ileana, E.2    Giaccone, G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.